Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 4 | 2 | — | 2 | 8 |
Leukemia | D007938 | — | C95 | 1 | 1 | 2 | — | — | 4 |
Myeloid leukemia | D007951 | — | C92 | 1 | 1 | 1 | — | — | 3 |
Myelodysplastic syndromes | D009190 | — | D46 | — | — | 2 | — | — | 2 |
Preleukemia | D011289 | — | — | — | — | 2 | — | — | 2 |
Syndrome | D013577 | — | — | — | — | 2 | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | — | 1 | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | — | — | 1 | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 1 | 7 | — | — | 1 | 8 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 5 | — | — | 1 | 6 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 3 | — | — | 1 | 5 |
Lung neoplasms | D008175 | — | C34.90 | — | 3 | — | — | 1 | 4 |
Sarcoma | D012509 | — | — | 1 | 2 | — | — | — | 3 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 3 | — | — | — | 3 |
Plasma cell neoplasms | D054219 | — | — | 1 | 3 | — | — | — | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 2 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 2 |
Hodgkin disease | D006689 | — | C81 | — | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Aids-related complex | D000386 | EFO_0007137 | B20 | 1 | — | — | — | 1 | 2 |
Immunologic deficiency syndromes | D007153 | — | D84.9 | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | — | — | — | — | 1 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
Germ cell and embryonal neoplasms | D009373 | — | — | 1 | — | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Nervous system neoplasms | D009423 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Graft vs host disease | D006086 | — | D89.81 | — | — | — | — | 1 | 1 |
Drug common name | Lenograstim |
INN | lenograstim |
Description | Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator. It is developed by Chugai Pharmaceuticals under the brand name Granocyte.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109128 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6WS4C399GB (ChemIDplus, GSRS) |